By
Ryan E.
|
January 7, 2024

Scalise To Miss Votes Through February Due To Cancer Treatment

America's GOP just received some very difficult news.

House Majority Leader Representative Steve Scalise's cancer treatment will require his temporary absence.

Scalise announced his diagnosis last summer but will now embark on a new type of treatment.

The Louisiana Republican is going to start his new course of attack imminently.

As a result, the House Majority Leader is expected to miss votes in Washington until at least February.

Scalise is going to spend January receiving a stem cell transplant.

His office released an official statement on the matter:

Last month, Leader Scalise successfully completed induction chemotherapy and had a positive response. It has now been determined he is eligible for an autologous stem cell transplant. He is currently undergoing the transplant process, marking a significant milestone in his battle against cancer. Once the procedure is completed, he will be recovering under the supervision of his medical team and will work remotely until returning to Washington next month. He is incredibly grateful to have progressed so well, and is thankful to his entire medical team, family, friends, and colleagues for their prayers and support.

Scalise's absence certainly comes at a tough time for a Republicans, but it's hard to blame him for doing what he needs to do in regard to his health.

Republicans already only have a very slim margin on votes in the House, and it looks as if that advantage just decreased by one, at least temporarily.

America's government faces funding deadlines on Jan. 19 and Feb. 2, dates by which Scalise will not yet have returned.

That means that liberals are going to be one vote closer to the advantage when it comes time to make decisions on those items.

Here's to a speedy recovery to Scalise.

I know that his family is probably counting on him to recover, but so is all of America.

To read more about this story, click on the source here.

Don't Wait
We publish the objective news, period. If you want the facts, then sign up below and join our movement for objective news:
Top stories
Newsletter
Get news from American Digest in your inbox.
By submitting this form, you are consenting to receive marketing emails from: American Digest, 3000 S. Hulen Street, Ste 124 #1064, Fort Worth, TX, 76109, US, http://americandigest.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact.